General Archive

Home » News releases » Page 21
  • News releases

    EU Consortium receives funding for detection and prevention of diseases associated with ageing

    Marie Skłodowska-Curie actions has awarded €2,887,054.24 to an EU consortium, including MRC Technology, to provide training for 11 young researchers…

    Read more

  • News releases

    Dementia Consortium funds project focusing on ALS and FTLD

    A project to identify new agents capable of stimulating clearance of a protein that forms aggregates in neurons of patients…

    Read more

  • News releases

    NICE recommends pembrolizumab made available on the NHS for advanced skin cancer (antibody humanized by MRC Technology)

    Pembrolizumab, an immunotherapy treatment for advanced melanoma (skin cancer), was approved by “The National Institute for Health and Care Excellence…

    Read more

  • News releases

    Georg-August-University Göttingen, Universitätsmedizin and MRC Technology collaborate to develop new therapy for neurodegenerative diseases

    Georg-August-University Göttingen (UMG) and MRC Technology (MRCT) have signed a collaboration agreement for the development of a novel therapy for…

    Read more

  • News releases

    Keytruda receives EU marketing approval (antibody humanised by MRC Technology)

    Keytruda receives European Commission approval for treatment of advanced melanoma in all EU member states.

    Read more

  • News releases

    MRC Technology appoints technology transfer director

    Andrew Farquharson has been appointed Director of Technology Transfer from 1 September.

    Read more

  • News releases

    Brain inflammation targeted in first drug discovery project from £3m Dementia Consortium

    Funding worth nearly half a million pounds will unite academics at the University of Southampton with drug discovery experts at…

    Read more

  • News releases

    MRC Technology and Peptinnovate collaborate on therapeutics for bone diseases

    Collaboration to assess the therapeutic potential in bone diseases of Peptinnovate’s unique peptides derived from the bacterium Mycobacterium tuberculosis.

    Read more

  • News releases

    Poster prize for presentation at Chemistry in Health Conference

    Ela Smiljanic-Hurley’s poster presentation at the Chemistry in Health Conference 2015, held on 26 May at the Royal Society of…

    Read more

  • News releases

    Dementia care digital platform launched by partnership including MRC Technology

    Brain health company IXICO launched a digital platform, Project Cygnus, to support patients with the diseases that cause dementia. IXICO…

    Read more

  • News releases

    MRC Technology collaborates with NYU School of Medicine to develop biologics for inflammatory bone disease

    MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory…

    Read more

  • News releases

    MRC Technology appoints Finance Director

    MRC Technology has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim…

    Read more